FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/03/105720 [Registered on: 09/03/2026] Trial Registered Prospectively
Last Modified On: 23/02/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Siddha 
Study Design  Single Arm Study 
Public Title of Study   A clinical trail on Chitramoola Ennai in the management of Thandagavatham (Lumbar Spondylosis) 
Scientific Title of Study   A PROSPECTIVE OPEN LABELLED, SINGLE ARM, NON- RANDOMIZED, SINGLE CENTRIC, PHASE II CLINICAL TRIAL TO DETERMINE THE EFFECTIVENESS OF CHITRAMOOLA ENNAI IN THE MANAGEMENT OF THANDAGAVATHAM (LUMBAR SPONDYLOSIS) 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
Nil  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DR S KAVITHA 
Designation  Pg scholar 
Affiliation  Government Siddha Medical College and Hospital  
Address  Op number 10, Department of Pothu Maruthuvam, Government Siddha Medical College and Hospital, Palayamkottai.

Tirunelveli
TAMIL NADU
627002
India 
Phone  8124668492  
Fax    
Email  kavithabsms2002@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr P Sathish Kumar  
Designation  Associate professor  
Affiliation  Government Siddha Medical College and Hospital  
Address  Op number 10, Department of Pothu maruthuvam, Government siddha Medical College and Hopital, Palayamkottai.

Tirunelveli
TAMIL NADU
627002
India 
Phone  9944337757  
Fax    
Email  drpsk_md@yahoo.in  
 
Details of Contact Person
Public Query
 
Name  Dr S Justus Antony  
Designation  Head of the department  
Affiliation  Government Siddha Medical College and Hospital  
Address  Op number 10, Department of Pothu Maruthuvam, Government Siddha Medical College and Hospital, palayamkottai.

Tirunelveli
TAMIL NADU
627002
India 
Phone  9443090849  
Fax    
Email  justusantony71@gmail.com  
 
Source of Monetary or Material Support  
OPD and OPD facilities and central library of Government Siddha Medical College and Hospital,Palayamkottai Tirunelveli 627002,Tamil Nadu, India. 
 
Primary Sponsor  
Name  Government siddha medical College and hospital  
Address  Government Siddha Medical College and Hospital Palayamkottai, Tirunelveli 627002 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR S KAVITHA   Government Siddha Medical College and Hospital   Op No 10, Department of Pothu Maruthuvam
Tirunelveli
TAMIL NADU 
8124668492

kavithabsms2002@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMMITTEE GOVERNMENT SIDDHA MEDICAL COLLEGE AND HOSPITAL PALAYAMKOTTAI ,TIRUNELVELI 627002  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M478||Other spondylosis,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  CHITRAMOOLA ENNAI   Dosage - 4 grams ( twice a day) after food for 40 days. 
Comparator Agent  Nil  Nil 
 
Inclusion Criteria  
Age From  30.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  Pain and stiffness in the lumbar region.
Patient presenting with or without radiating pain to lower limb.
Difficulty in range of motion Femoral nerve stretch test-Positive.
Patient who are willing to participate in the study.  
 
ExclusionCriteria 
Details  Osteoarthritis of hip.
Patient undergone spinal surgery.
TB-Spine.
SLE.
Infection.
Rheumatoid arthritis.
Fracture of spine.
Chronic renal and liver disease patients.
Pregnancy and Lactation  
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
The outcome will be aimed at to
Determine the clinical effectiveness of CHITRAMOOLA ENNAI (INTERNAL) in the management of THANDAGAVATHAM( LUMBER SPONDYLOSIS).
Reduced the pain and stiffness affect site.Improve the range of motion

 
40 days 
 
Secondary Outcome  
Outcome  TimePoints 
To collect various Siddha literatures and modern journals for literature review on THANDAGAVATHAM.
To study other cofactors related to disease like age, sex, dietary habits, family history, and socioeconomic status.
To perform physicochemical, phytochemical, bio chemical analysis of CHITRAMOOLA ENNAI. To evaluate safety profile for CHITRAMOOLA ENNAI acute and sub-acute toxicity. 
6 months  
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   25/03/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This is a“A PROSPECTIVE OPEN LABELLED, SINGLE ARM, NON- RANDOMIZED, SINGLE CENTRIC, PHASE II CLINICAL TRIAL TO DETERMINE THE EFFECTIVENESS OF CHITRAMOOLA ENNAI IN THE MANAGEMENT OF THANDAGAVATHAM (LUMBAR SPONDYLOSIS) after purification of trial drug CHITRAMOOLA ENNAI is prepared and administered at the dosage of 4 grams for 40 days which is given to 40 known lumbar spondylosis patient (20 OP+20 IP patients).The primary outcome will be determine the therapeutic efficacy of CHITRAMOOLA ENNAI in the management of thandaga vatham (Lumbar spondylosis).The secondary out come will be to collect various siddha literatures on THANDAGAVATHAM to perform physicochemical ,phytochemical,biochemical analysis of CHITRAMOOLA ENNAI to evaluate safety profile for acute and sub-acute toxicity of CHITRAMOOLA ENNAI to evaluate pharmacological activities of CHITRAMOOLA ENNAI  to study about the prevalence of THANDAGAVATHAM in  relationship with diet and lifestyle ,to evaluate siddha parameters(including Envagaithervu ,Neerkuri - Neikuri) changes and dhegi of THANDAGAVATHAM patients during trail period ,to evaluate modern parametric changes in THANDAGAVATHAM to assess the quality of life of THANDAGAVATHAM  patients and to document Bio statistical analysis . 
Close